C vs FOLD · P/E 16, rev $85.22B vs rev $528.3M
Citigroup Inc. (C) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
C currently screens at market cap $214.73B and trailing P/E 15.5. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the C and FOLD stock pages for the full models.
Not investment advice.